INTERFERON-GAMMA IN CEREBROSPINAL-FLUID FROM PATIENTS WITH VIRAL AND BACTERIAL-MENINGITIS

被引:31
作者
GLIMAKER, M
OLCEN, P
ANDERSSON, B
机构
[1] OREBRO MED CTR HOSP,DEPT INFECT DIS,STOCKHOLM,SWEDEN
[2] OREBRO MED CTR HOSP,DEPT CLIN MICROBIOL & IMMUNOL,STOCKHOLM,SWEDEN
[3] STOCKHOLM CTY COUNCIL,CENT MICROBIOL LAB,DEPT VIROL,S-10726 STOCKHOLM,SWEDEN
[4] NATL BACTERIOL LAB,DEPT IMMUNOL,S-10521 STOCKHOLM,SWEDEN
关键词
D O I
10.3109/00365549409011777
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Interferon (IFN)-gamma was analysed immunologically in cerebrospinal fluid (CSF) sampled in the acute phase from 27 patients (15-66 years) with viral meningitis and from 18 patients (0.5-90 years) with bacterial meningitis. Increased CSF concentrations were observed in 19/27 viral and in 13/18 bacterial cases. CSF-IFN-gamma did not distinguish between viral and bacterial meningitis. Five of 8 patients with meningitis due to herpes simplex virus type 2 (HSV-2) had CSF-IFN-gamma levels above the highest found in enteroviral meningitis. Thus, a markedly increased CSF-IFN-gamma value in patients with suspected viral meningitis ought to indicate HSV-2 etiology. The patients with Streptococcus pneumoniae meningitis (6 adults and 1 child) had significantly higher levels than the 7 children with Haemophilus influenzae meningitis. This may indicate that S. pneumoniae induces more IFN-gamma secretion than H. influenzas, and/or that during meningitis, adults are more apt to react with IFN-gamma production, than are children.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 21 条
[1]   IMMUNOREACTIVE IFN-GAMMA IN CSF IN NEUROLOGICAL DISORDERS [J].
ABBOTT, RJ ;
BOLDERSON, I ;
GRUER, PJK ;
PEATFIELD, RC .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (07) :882-885
[2]  
AURELIUS E, IN PRESS J INFECT DI
[3]  
CHONMAITREE T, 1991, REV INFECT DIS, V13, P1061
[4]  
FIERZ W, 1985, J IMMUNOL, V134, P3785
[5]   HOW USEFUL ARE SERUM AND CSF INTERFERON LEVELS AS A RAPID DIAGNOSTIC-AID IN VIRUS-INFECTIONS [J].
FLOWERS, D ;
SCOTT, GM .
JOURNAL OF MEDICAL VIROLOGY, 1985, 15 (01) :35-47
[6]  
FONTANA A, 1985, S IMMUNOPATHOLOGY
[7]  
FREI, 1988, J EXP MED, V168, P149
[8]  
GRESSER I, 1964, P SOC EXP BIOL MED, V117, P285, DOI 10.3181/00379727-117-29559
[9]  
GUSTAVSONMORING.IL, 1988, J CLIN LAB IMMUNOL, V26, P85
[10]  
HAAHR S, 1968, ACTA PATHOL MIC SC, V73, P264